The significance of adiponectin as a biomarker in metabolic syndrome and/or coronary artery disease [PDF]
Vojnosanitetski Pregled, 2015 Introduction/Aim. Adiponectin exerts profound protective actions during insulin resistence or prediabetes progression towards more severe clinical entities such as metabolic syndrome and/or cardiovascular disease.
Stojanović Sanja +4 more
doaj +1 more source
Revista de Saúde Pública, 2008 OBJETIVO: Analisar as evidências na literatura do efeito do peso ao nascer sobre a ocorrência de síndrome metabólica em adultos. MÉTODOS: Foram pesquisados nas bases PubMed and LILACS, no período de 1966 a maio de 2006, artigos publicados usando os ...
Vera Maria Freitas da Silveira +1 more
doaj +1 more source
Discrepancies in occurrence of metabolic disturbances related to gender among young people
Family Medicine & Primary Care Review, 2017 Background . Metabolic disturbances are the most establishing risk factors for cardiovascular diseases at an elderly age. Early identification and behavioral or pharmacological treatment of metabolic abnormalities is the best way to prevent ...
Sylwia Płaczkowska +3 more
doaj +1 more source
Metabolic and Body Composition Risk Factors Associated with Metabolic Syndrome in a Cohort of Women with a High Prevalence of Cardiometabolic Disease. [PDF]
PLoS ONE, 2016 BACKGROUND:The aetiology of the metabolic syndrome and the inter-relationship between risk factors for this syndrome are poorly understood. The purpose of this investigation was to determine the risk factors for metabolic syndrome and their interactions ...
Philippe Jean-Luc Gradidge +3 more
doaj +1 more source
The Impact of Metabolic Syndrome Components on Erectile Function in Patients with Type 2 Diabetes
Metabolites, 2023 Erectile dysfunction is commonly encountered in diabetic patients and in patients with metabolic syndrome; however, only a few studies have assessed patients with metabolic syndrome and type 2 diabetes mellitus (T2DM) regarding their sexual function. The
Alexandra Katsimardou +11 more
doaj +1 more source
Anesthetic challenges in a child with Lowe's and Fanconi syndrome
Indian Journal of Anaesthesia, 2018 Oculocerebrorenal syndrome of Lowe is a rare X-linked metabolic disorder complicated by Fanconi's syndrome. Anaesthetic management of Lowe syndrome with Fanconi's syndrome is challenging to the anaesthesiologists in view of difficult airway due to ...
Shital Digambar Chaudhari, Manpreet Kaur
doaj +1 more source
Prevalence and Influencing Factors of Metabolic Syndrome Among Persons with Physical Disabilities
Asian Nursing Research, 2018 Purpose: Metabolic syndrome is an important cluster of coronary heart disease risk factors. However, it remains unclear to what extent metabolic syndrome is associated with demographic and potentially modifiable lifestyle factors among Korean persons ...
Jeonghee Jeong, RN, PhD +1 more
doaj +1 more source
Are Metabolic Risk Factors One Unified Syndrome? Modeling the Structure of the Metabolic Syndrome X [PDF]
American Journal of Epidemiology, 2003 The metabolic syndrome, manifested by insulin resistance, obesity, dyslipidemia, and hypertension, is conceived to increase the risk for coronary heart disease and type II diabetes. Several studies have used factor analysis to explore its underlying structure among related risk variables but reported different results.
Biing-Jiun, Shen +6 more
openaire +2 more sources
Association between oxidative balance score and metabolic syndrome: a systematic review and meta-analysis [PDF]
Journal of NephropathologyIntroduction: Most patients with metabolic syndrome (MetS) are at enhanced risk of oxidative stress. This systematic review and meta-analysis assesses the association between oxidative balance score (OBS) and MetS (MetS). Method: Cochrane, Web of Science,
Aliasghar Tabatabaei Mohammadi +8 more
doaj +1 more source
HYPERTENSION MANAGEMENT IN METABOLIC SYNDROME
Архивъ внутренней медицины, 2019 Hypertension is one of the key risk factors for cardiovascular morbidity and mortality. Metabolic syndrome (synonyms: syndrome X, insulin resistance syndrome) is characterized by increased visceral fat mass, decreased sensitivity of peripheral tissues to
E. V. Reznik, I. G. Nikitin
doaj +1 more source